Gil Yosipovitch, MD: New Analysis of Data on Patient Satisfaction with Dupilumab for Prurigo Nodularis

This discussion with Dr. Yosipovitch covered findings presented at EADV 2023 on dupilumab and prurigo nodularis patients’ satisfaction.

Related Keywords

Gil Yosipovitch ,European Academy Of Dermatology ,University Of Miami ,Miller School Of Medicine ,Miller School ,Nature Medicine ,Espn ,Prurigo Nodularis ,Dupilumab ,Satisfaction ,Jeeadv ,